TY - JOUR PY - 2002 DA - 2002// TI - K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification JO - Am J Kidney Dis VL - 39 ID - ref1 ER - TY - JOUR PY - 2013 DA - 2013// TI - KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease JO - Kidney Int Suppl VL - 3 UR - https://doi.org/10.1038/kisup.2012.73 DO - 10.1038/kisup.2012.73 ID - ref2 ER - TY - JOUR AU - Coresh, J. AU - Selvin, E. AU - Stevens, L. A. AU - Manzi, J. AU - Kusek, J. W. AU - Eggers, P. AU - Van Lente, F. AU - Levey, A. S. PY - 2007 DA - 2007// TI - Prevalence of chronic kidney disease in the United States JO - JAMA VL - 298 UR - https://doi.org/10.1001/jama.298.17.2038 DO - 10.1001/jama.298.17.2038 ID - Coresh2007 ER - TY - JOUR AU - Sarnak, M. J. AU - Levey, A. S. PY - 2000 DA - 2000// TI - Cardiovascular disease and chronic renal disease: a new paradigm JO - Am J Kidney Dis VL - 35 UR - https://doi.org/10.1016/S0272-6386(00)70239-3 DO - 10.1016/S0272-6386(00)70239-3 ID - Sarnak2000 ER - TY - JOUR AU - Sarnak, M. J. AU - Levey, A. S. AU - Schoolwerth, A. C. AU - Coresh, J. AU - Culleton, B. AU - Hamm, L. L. AU - McCullough, P. A. AU - Kasiske, B. L. AU - Kelepouris, E. AU - Klag, M. J. AU - Parfrey, P. AU - Pfeffer, M. AU - Raij, L. AU - Spinosa, D. J. AU - Wilson, P. W. PY - 2003 DA - 2003// TI - Kidney disease as a risk factor for development of cardiovascular disease: a statement from the american heart association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention JO - Circulation VL - 108 UR - https://doi.org/10.1161/01.CIR.0000095676.90936.80 DO - 10.1161/01.CIR.0000095676.90936.80 ID - Sarnak2003 ER - TY - JOUR AU - Tonelli, M. AU - Wiebe, N. AU - Culleton, B. AU - House, A. AU - Rabbat, C. AU - Fok, M. AU - McAlister, F. AU - Garg, A. X. PY - 2006 DA - 2006// TI - Chronic kidney disease and mortality risk: a systematic review JO - J Am Soc Nephrol VL - 17 UR - https://doi.org/10.1681/ASN.2005101085 DO - 10.1681/ASN.2005101085 ID - Tonelli2006 ER - TY - JOUR AU - Collins, A. J. AU - Li, S. AU - Gilbertson, D. T. AU - Liu, J. AU - Chen, S. C. AU - Herzog, C. A. PY - 2003 DA - 2003// TI - Chronic kidney disease and cardiovascular disease in the Medicare population JO - Kidney Int VL - 64 UR - https://doi.org/10.1046/j.1523-1755.64.s87.5.x DO - 10.1046/j.1523-1755.64.s87.5.x ID - Collins2003 ER - TY - JOUR AU - Go, A. S. AU - Chertow, G. M. AU - Fan, D. AU - McCulloch, C. E. AU - Hsu, C. Y. PY - 2004 DA - 2004// TI - Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa041031 DO - 10.1056/NEJMoa041031 ID - Go2004 ER - TY - JOUR AU - Keith, D. S. AU - Nichols, G. A. AU - Gullion, C. M. AU - Brown, J. B. AU - Smith, D. H. PY - 2004 DA - 2004// TI - Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization JO - Arch Intern Med VL - 164 UR - https://doi.org/10.1001/archinte.164.6.659 DO - 10.1001/archinte.164.6.659 ID - Keith2004 ER - TY - JOUR AU - Levey, A. S. AU - Beto, J. A. AU - Coronado, B. E. AU - Eknoyan, G. AU - Foley, R. N. AU - Kasiske, B. L. AU - Klag, M. J. AU - Mailloux, L. U. AU - Manske, C. L. AU - Meyer, K. B. AU - Parfrey, P. S. AU - Pfeffer, M. A. AU - Wenger, N. K. AU - Wilson, P. W. AU - Wright, J. T. PY - 1998 DA - 1998// TI - Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease JO - Am J Kidney Dis VL - 32 UR - https://doi.org/10.1016/S0272-6386(98)70145-3 DO - 10.1016/S0272-6386(98)70145-3 ID - Levey1998 ER - TY - JOUR PY - 2003 DA - 2003// TI - K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease JO - Am J Kidney Dis VL - 41 ID - ref11 ER - TY - JOUR PY - 2004 DA - 2004// TI - K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease JO - Am J Kidney Dis VL - 43 ID - ref12 ER - TY - JOUR AU - Kasiske, B. L. PY - 1998 DA - 1998// TI - Hyperlipidemia in patients with chronic renal disease JO - Am J Kidney Dis VL - 32 UR - https://doi.org/10.1053/ajkd.1998.v32.pm9820472 DO - 10.1053/ajkd.1998.v32.pm9820472 ID - Kasiske1998 ER - TY - JOUR AU - Mailloux, L. U. AU - Levey, A. S. PY - 1998 DA - 1998// TI - Hypertension in patients with chronic renal disease JO - Am J Kidney Dis VL - 32 UR - https://doi.org/10.1053/ajkd.1998.v32.pm9820471 DO - 10.1053/ajkd.1998.v32.pm9820471 ID - Mailloux1998 ER - TY - JOUR AU - Tonelli, M. AU - Isles, C. AU - Curhan, G. C. AU - Tonkin, A. AU - Pfeffer, M. A. AU - Shepherd, J. AU - Sacks, F. M. AU - Furberg, C. AU - Cobbe, S. M. AU - Simes, J. AU - Craven, T. AU - West, M. PY - 2004 DA - 2004// TI - Effect of pravastatin on cardiovascular events in people with chronic kidney disease JO - Circulation VL - 110 UR - https://doi.org/10.1161/01.CIR.0000143892.84582.60 DO - 10.1161/01.CIR.0000143892.84582.60 ID - Tonelli2004 ER - TY - JOUR AU - Shepherd, J. AU - Kastelein, J. J. P. AU - Bittner, V. AU - Deedwania, P. AU - Breazna, A. AU - Dobson, S. AU - Wilson, D. J. AU - Zuckerman, A. AU - Wenger, N. K. PY - 2008 DA - 2008// TI - Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the treating to new targets (TNT) study JO - J Am Coll Cardiol VL - 51 UR - https://doi.org/10.1016/j.jacc.2007.11.072 DO - 10.1016/j.jacc.2007.11.072 ID - Shepherd2008 ER - TY - JOUR AU - Koren, M. J. AU - Davidson, M. H. AU - Wilson, D. J. AU - Fayyad, R. S. AU - Zuckerman, A. AU - Reed, D. P. PY - 2009 DA - 2009// TI - Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD JO - Am J Kidney Dis VL - 53 UR - https://doi.org/10.1053/j.ajkd.2008.11.025 DO - 10.1053/j.ajkd.2008.11.025 ID - Koren2009 ER - TY - JOUR AU - Ridker, P. M. AU - MacFadyen, J. AU - Cressman, M. AU - Glynn, R. J. PY - 2010 DA - 2010// TI - Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (justification for the use of statins in prevention—an intervention trial evaluating rosuvastatin) trial JO - J Am Coll Cardiol VL - 55 UR - https://doi.org/10.1016/j.jacc.2010.01.020 DO - 10.1016/j.jacc.2010.01.020 ID - Ridker2010 ER - TY - JOUR AU - Pahor, M. AU - Shorr, R. I. AU - Somes, G. W. AU - Cushman, W. C. AU - Ferrucci, L. AU - Bailey, J. E. AU - Elam, J. T. AU - Applegate, W. B. PY - 1998 DA - 1998// TI - Diuretic-based treatment and cardiovascular events in patients with mild renal dysfunction enrolled in the systolic hypertension in the elderly program JO - Arch Intern Med VL - 158 UR - https://doi.org/10.1001/archinte.158.12.1340 DO - 10.1001/archinte.158.12.1340 ID - Pahor1998 ER - TY - JOUR AU - Mann, J. F. AU - Gerstein, H. C. AU - Pogue, J. AU - Bosch, J. AU - Yusuf, S. PY - 2001 DA - 2001// TI - Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial JO - Ann Intern Med VL - 134 UR - https://doi.org/10.7326/0003-4819-134-8-200104170-00007 DO - 10.7326/0003-4819-134-8-200104170-00007 ID - Mann2001 ER - TY - JOUR AU - Tonelli, M. AU - Isles, C. AU - Craven, T. AU - Tonkin, A. AU - Pfeffer, M. A. AU - Shepherd, J. AU - Sacks, F. M. AU - Furberg, C. AU - Cobbe, S. M. AU - Simes, J. AU - West, M. AU - Packard, C. AU - Curhan, G. C. PY - 2005 DA - 2005// TI - Effect of pravastatin on rate of kidney function loss in people with or at risk for coronary disease JO - Circulation VL - 112 UR - https://doi.org/10.1161/CIRCULATIONAHA.104.517565 DO - 10.1161/CIRCULATIONAHA.104.517565 ID - Tonelli2005 ER - TY - JOUR AU - Shepherd, J. AU - Kastelein, J. J. P. AU - Bittner, V. AU - Deedwania, P. AU - Breazna, A. AU - Dobson, S. AU - Wilson, D. J. AU - Zuckerman, A. AU - Wenger, N. K. PY - 2007 DA - 2007// TI - Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the treating to new targets (TNT) study JO - CJASN VL - 2 UR - https://doi.org/10.2215/CJN.04371206 DO - 10.2215/CJN.04371206 ID - Shepherd2007 ER - TY - JOUR AU - Vidt, D. G. AU - Ridker, P. M. AU - Monyak, J. T. AU - Schreiber, M. J. AU - Cressman, M. D. PY - 2011 DA - 2011// TI - Longitudinal assessment of estimated glomerular filtration rate in apparently healthy adults: a post hoc analysis from the JUPITER study (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin) JO - Clin Ther VL - 33 UR - https://doi.org/10.1016/j.clinthera.2011.05.004 DO - 10.1016/j.clinthera.2011.05.004 ID - Vidt2011 ER - TY - BOOK PY - 2001 DA - 2001// TI - About the National Health and Nutrition Examination Survey ID - ref24 ER - TY - BOOK PY - 2001 DA - 2001// TI - National Health and Nutrition Examination Survey questionnaires, datasets, and related documentation ID - ref25 ER - TY - JOUR AU - Levey, A. S. AU - Stevens, L. A. AU - Schmid, C. H. AU - Zhang, Y. L. AU - Castro, A. F. AU - Feldman, H. I. AU - Kusek, J. W. AU - Eggers, P. AU - Van Lente, F. AU - Greene, T. AU - Coresh, J. PY - 2009 DA - 2009// TI - A new equation to estimate glomerular filtration rate JO - Ann Intern Med VL - 150 UR - https://doi.org/10.7326/0003-4819-150-9-200905050-00006 DO - 10.7326/0003-4819-150-9-200905050-00006 ID - Levey2009 ER - TY - JOUR PY - 2001 DA - 2001// TI - Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.19.2486 DO - 10.1001/jama.285.19.2486 ID - ref27 ER - TY - JOUR AU - Grundy, S. M. AU - Cleeman, J. I. AU - Merz, C. N. AU - Brewer, H. B. AU - Clark, L. T. AU - Hunninghake, D. B. AU - Pasternak, R. C. AU - Smith, S. C. AU - Stone, N. J. PY - 2004 DA - 2004// TI - Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines JO - Circulation VL - 110 UR - https://doi.org/10.1161/01.CIR.0000133317.49796.0E DO - 10.1161/01.CIR.0000133317.49796.0E ID - Grundy2004 ER - TY - JOUR PY - 2006 DA - 2006// TI - AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Endorsed by the national heart, lung, and blood institute JO - Circulation VL - 113 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.174516 DO - 10.1161/CIRCULATIONAHA.106.174516 ID - ref29 ER - TY - JOUR PY - 2007 DA - 2007// TI - KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease JO - Am J Kidney Dis VL - 49 ID - ref30 ER - TY - JOUR AU - Wanner, C. AU - Krane, V. AU - Marz, W. AU - Olschewski, M. AU - Mann, J. F. AU - Ruf, G. AU - Ritz, E. PY - 2005 DA - 2005// TI - Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis JO - N Engl J Med VL - 353 UR - https://doi.org/10.1056/NEJMoa043545 DO - 10.1056/NEJMoa043545 ID - Wanner2005 ER - TY - JOUR AU - Fellstrom, B. C. AU - Jardine, A. G. AU - Schmieder, R. E. AU - Holdaas, H. AU - Bannister, K. AU - Beutler, J. AU - Chae, D. W. AU - Chevaile, A. AU - Cobbe, S. M. AU - Gronhagen-Riska, C. AU - De Lima, J. J. AU - Lins, R. AU - Mayer, G. AU - McMahon, A. W. AU - Parving, H. H. AU - Remuzzi, G. AU - Samuelsson, O. AU - Sonkodi, S. AU - Sci, D. AU - Suleymanlar, G. AU - Tsakiris, D. AU - Tesar, V. AU - Todorov, V. AU - Wiecek, A. AU - Wuthrich, R. P. AU - Gottlow, M. AU - Johnsson, E. AU - Zannad, F. PY - 2009 DA - 2009// TI - Rosuvastatin and cardiovascular events in patients undergoing hemodialysis JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0810177 DO - 10.1056/NEJMoa0810177 ID - Fellstrom2009 ER - TY - JOUR AU - Holdaas, H. AU - Fellstrom, B. AU - Jardine, A. G. AU - Holme, I. AU - Nyberg, G. AU - Fauchald, P. AU - Gronhagen-Riska, C. AU - Madsen, S. AU - Neumayer, H. H. AU - Cole, E. AU - Maes, B. AU - Ambuhl, P. AU - Olsson, A. G. AU - Hartmann, A. AU - Solbu, D. O. AU - Pedersen, T. R. PY - 2003 DA - 2003// TI - Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial JO - Lancet VL - 361 UR - https://doi.org/10.1016/S0140-6736(03)13638-0 DO - 10.1016/S0140-6736(03)13638-0 ID - Holdaas2003 ER - TY - JOUR AU - Strippoli, G. F. AU - Navaneethan, S. D. AU - Johnson, D. W. AU - Perkovic, V. AU - Pellegrini, F. AU - Nicolucci, A. AU - Craig, J. C. PY - 2008 DA - 2008// TI - Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials JO - BMJ VL - 336 UR - https://doi.org/10.1136/bmj.39472.580984.AE DO - 10.1136/bmj.39472.580984.AE ID - Strippoli2008 ER - TY - STD TI - Navaneethan SD, Pansini F, Perkovic V, Manno C, Pellegrini F, Johnson DW, Craig JC, Strippoli GF: HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev. 2009, CD007784-10.1002/14651858.CD007784. 2 ID - ref35 ER - TY - JOUR AU - Tonelli, M. AU - Moye, L. AU - Sacks, F. M. AU - Kiberd, B. AU - Curhan, G. PY - 2003 DA - 2003// TI - Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency JO - Ann Intern Med VL - 138 UR - https://doi.org/10.7326/0003-4819-138-2-200301210-00010 DO - 10.7326/0003-4819-138-2-200301210-00010 ID - Tonelli2003 ER - TY - JOUR PY - 2011 DA - 2011// TI - The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(11)60739-3 DO - 10.1016/S0140-6736(11)60739-3 ID - ref37 ER - TY - CHAP AU - Arguedas, J. A. AU - Perez, M. I. AU - Wright, J. M. PY - 2009 DA - 2009// TI - Treatment blood pressure targets for hypertension BT - Cochrane Database Syst Rev ID - Arguedas2009 ER - TY - JOUR AU - Matsushita, K. AU - Selvin, E. AU - Bash, L. D. AU - Astor, B. C. AU - Coresh, J. PY - 2010 DA - 2010// TI - Risk implications of the new CKD epidemiology collaboration (CKD-EPI) equation compared with the MDRD study equation for estimated GFR: the atherosclerosis risk in communities (ARIC) study JO - Am J Kidney Dis VL - 55 UR - https://doi.org/10.1053/j.ajkd.2009.12.016 DO - 10.1053/j.ajkd.2009.12.016 ID - Matsushita2010 ER - TY - JOUR AU - Stevens, L. A. AU - Li, S. AU - Kurella Tamura, M. AU - Chen, S. C. AU - Vassalotti, J. A. AU - Norris, K. C. AU - Whaley-Connell, A. T. AU - Bakris, G. L. AU - McCullough, P. A. PY - 2011 DA - 2011// TI - Comparison of the CKD epidemiology collaboration (CKD-EPI) and modification of diet in renal disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the kidney early evaluation program (KEEP) JO - Am J Kidney Dis VL - 57 UR - https://doi.org/10.1053/j.ajkd.2010.11.007 DO - 10.1053/j.ajkd.2010.11.007 ID - Stevens2011 ER - TY - BOOK PY - 2012 DA - 2012// TI - USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States PB - National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases CY - Bethesda, MD ID - ref41 ER - TY - JOUR AU - Levey, A. S. AU - Eckardt, K. U. AU - Tsukamoto, Y. AU - Levin, A. AU - Coresh, J. AU - Rossert, J. AU - De Zeeuw, D. AU - Hostetter, T. H. AU - Lameire, N. AU - Eknoyan, G. PY - 2005 DA - 2005// TI - Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO) JO - Kidney Int VL - 67 UR - https://doi.org/10.1111/j.1523-1755.2005.00365.x DO - 10.1111/j.1523-1755.2005.00365.x ID - Levey2005 ER - TY - JOUR AU - Eckardt, K. U. AU - Berns, J. S. AU - Rocco, M. V. AU - Kasiske, B. L. PY - 2009 DA - 2009// TI - Definition and classification of CKD: the debate should be about patient prognosis. A position statement from KDOQI and KDIGO JO - Am J Kidney Dis VL - 53 UR - https://doi.org/10.1053/j.ajkd.2009.04.001 DO - 10.1053/j.ajkd.2009.04.001 ID - Eckardt2009 ER - TY - JOUR AU - Hallan, S. I. AU - Orth, S. R. PY - 2010 DA - 2010// TI - The KDOQI 2002 classification of chronic kidney disease: for whom the bell tolls JO - Nephrol Dial Transplant VL - 25 UR - https://doi.org/10.1093/ndt/gfq370 DO - 10.1093/ndt/gfq370 ID - Hallan2010 ER - TY - JOUR AU - Brantsma, A. H. AU - Bakker, S. J. AU - Hillege, H. L. AU - de Zeeuw, D. AU - de Jong, P. E. AU - Gansevoort, R. T. PY - 2008 DA - 2008// TI - Cardiovascular and renal outcome in subjects with K/DOQI stage 1–3 chronic kidney disease: the importance of urinary albumin excretion JO - Nephrol Dial Transplant VL - 23 UR - https://doi.org/10.1093/ndt/gfn356 DO - 10.1093/ndt/gfn356 ID - Brantsma2008 ER - TY - BOOK PY - 2010 DA - 2010// TI - USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States PB - National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases CY - Bethesda, MD ID - ref46 ER - TY - JOUR AU - Smith, D. H. AU - Gullion, C. M. AU - Nichols, G. AU - Keith, D. S. AU - Brown, J. B. PY - 2004 DA - 2004// TI - Cost of medical care for chronic kidney disease and comorbidity among enrollees in a large HMO population JO - J Am Soc Nephrol VL - 15 UR - https://doi.org/10.1097/01.ASN.0000125670.64996.BB DO - 10.1097/01.ASN.0000125670.64996.BB ID - Smith2004 ER - TY - JOUR AU - Menzin, J. AU - Lines, L. M. AU - Weiner, D. E. AU - Neumann, P. J. AU - Nichols, C. AU - Rodriguez, L. AU - Agodoa, I. AU - Mayne, T. PY - 2011 DA - 2011// TI - A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy JO - PharmacoEconomics VL - 29 UR - https://doi.org/10.2165/11588390-000000000-00000 DO - 10.2165/11588390-000000000-00000 ID - Menzin2011 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/14/132/prepub UR - http://www.biomedcentral.com/1471-2369/14/132/prepub ID - ref49 ER -